Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse

  • 32 Accesses

  • 8 Citations


The purpose of this work was twofold: 1 to learn whether rats transgenic for HLA-B27 and the human β2-microglobulin gene HB2M can mount B27-restricted cytolytic T lymphocyte (CTL) responses to the male H-Y antigen, and 2 to learn whether such CTLs would recognize both rat and mouse H-Y in the context of HLA-B27. Female rats of the B27/HB2M transgenic line 21-4L were primed in vivo with cells from males of the same line. CTL effectors were generated from lymph node cells of these females following culture with irradiated antigen-presenting cells from either male 21-4L rats or male mice of the B27/HB2M transgenic 56-3 line. The CTLs showed male-specific, B27-specific lysis of both rat and mouse targets. Lysis of B27 targets was inhibitable by monoclonal antibodies specific for B27 or rat CD8. Specific lysis of male B27 rat and mouse targets was inhibitable equally by either rat or mouse male B27 cold targets, but not significantly by female or nontransgenic cold targets. The B27-restricted CTLs neither recognized nor were inhibited by B27+ or B27- male or female human targets. These results demonstrate that CD8+, B27-restricted, anti-H-Y CTLs recognize and evolutionarily conserved H-Y peptide antigen in both rats and mice. In addition, they establish the transgenic rat as a model system for examining the T-cell response to antigen presented by class I HLA molecules.

This is a preview of subscription content, log in to check access.


  1. Benjamin, R. and Parham, P. Guilt by association: HLA-B27 and ankylosing spondylitis. Immunol Today 11: 137–142, 1990

  2. Brideau, R. J., Carter, P. B., McMaster, W. R., Mason, D. W., and Williams, A. F. Two subsets of rat T lymphocytes defined with monoclonal antibodies. Eur J Immunol 10: 609–615, 1980

  3. Butcher, G. W. A list of monoclonal antibodies specific for alloantigens of the rat. J Immunogenetics 14: 163–176, 1987

  4. Cantrell, M. A., Bogan, J. S., Simpson, E., Bicknell, J. N., Goulmy, E., Chandler, P., Pagon, R. A., Walker, D. C., Thuline, H. C., Graham, Jr., J. M., de la Chapelle, A., Page, D. C., and Disteche, C. M. Deletion mapping of H-Y antigen to the long arm of the human Y chromosome. Genomics 13: 1255–1260, 1992

  5. Falk, K., Rötzschke, O., and Rammensee, H.-G. Cellular peptide composition governed by major histocompatibility complex class I molecules. Nature 348: 248–251, 1990

  6. Falk, K., Rötzschke, O., and Rammensee, H.-G. Specificity of antigen processing for MHC class I restricted presentation is conserved between mouse and man. Eur J Immunol 22: 1323–1326, 1992

  7. Fukumoto, T., McMaster, W. R., and Williams, A. F. Mouse monoclonal antibodies against rat major histocompatibility antigens. Two Ia antigens and expression of Ia and class I antigens in rat thymus. Eur J Immunol 12: 237–243, 1982

  8. Goulmy, E., Termijtelen, A., Bradley, B. A., and van Rood, J. J. Y-antigen killing by T cells of women is restricted by HLA. Nature 266: 544–545, 1977

  9. Günther, E. Immunologic markers. In E. J. Hedrich (ed.): Genetic Monitoring of Inbred Strains of Rats, pp. 23–35, Gustav Fischer, Stuttgart, 1990

  10. Hammer, R. E., Maika, S. D., Richardson, J. A., Tang, J.-P., and Taurog, J. D. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human β2m: an animal model of HLA-B27-associated human disorders. Cell 63: 1099–1112, 1990

  11. Hart, D. N. J. and Fabre, J. W. MHC antigens in rat kidney, ureter, and bladder: localisation with monoclonal antibodies and demonstration of Ia positive dendritic cells. Transplantation 31: 318–325, 1981

  12. Hoffman, R. A., Kung, P. C., Hansen, W. P., and Goldstein, G. Simple and rapid measurement of human T lymphocytes and their subclasses in peripheral blood. Proc Natl Acad Sci USA 77: 4914–4917, 1980

  13. Kalinke, U., Arnold, B. A., and Hämmerling, G. J. Strong xenogeneic HLA response in transgenic mice after introducing an α3 domain into HLA-B27. Nature 348: 642–644, 1990

  14. Keller, R. and Keist, R. Induction of interleukin 1 secretion and of tumoricidal activity in macrophages are not closely related phenomena. Eur J Immunol 17: 1665–1668, 1987

  15. Kievits, F., Ivanyi, P., Krimpenfort, P., Berns, A., and Ploegh, H. L. HLA-restricted recognition of viral antigens in HLA transgenic mice. Nature 329: 447–449, 1987

  16. Kunz, H. W. and Gill, T. J., III: Red blood cell alloantigenic systems in the rat. J Immunogenet 5: 365–382, 1978

  17. Livingstone, A. M., Powis, S. J., Diamond, A. G., Butcher, G. W., and Howard, J. C. A trans-acting major histocompatibility complex-linked gene whose alleles determine gain and loss changes in the antigenic structure of a classical class I molecule. J Exp Med 170: 777–795, 1989

  18. Miyachi, Y., Wee, S.-L., Chen, L.-K., Grumet, F. C., Bowman, R. J., and Taurog, J. D. A cytolytic human T lymphocyte clone differentially recognizing HLA-B27 subtypes. Hum Immunol 10: 237–249, 1984

  19. Moots, R. J., Samberg, N. L., Pazmany, L., Frelinger, J. A., McMichael, A. J., and Stauss, H. J. A cross-species functional interaction between the murine major histocompatibility complex class I α3 domain and human CD8 revealed by peptide-specific cytotoxic T lymphocytes. Eur J Immunol 22: 1643–1646, 1992

  20. Ozato, K., Mayer, N., and Sachs, D. H. Hybridoma cell lines secreting monoclonal antibodies to mouse H-2 and Ia antigens. J Immunol 124: 533–540, 1980

  21. Ozato, K. and Sachs, D. H. Monoclonal antibodies to mouse MHC antigens. III. Hybridoma antibodies reacting to antigens of the H-2 b haplotype reveal genetic control of isotype expression. J Immunol 126: 317–321, 1981

  22. Rammensee, H.-G. and Klein, J. Polymorphism of minor histocompatibility genes in wild mice. Immunogenetics 17: 637–647, 1983

  23. Rebaï, N. and Malissen, B. Structural and genetic analyses of HLA class I molecules using monoclonal xenoantibodies. Tissue Antigens 22: 107–117, 1983

  24. Roopenian, D. C. What are minor histocompatibility loci? A new look at an old question. Immunol Today 13: 7–10, 1992

  25. Roopenian, D. C., Christianson, G. J., Davis, A. P., Zuberi, A. R., and Mobraaten, L. E. The genetic origin of minor histocompatibility antigens. Immunogenetics 38: 131–140, 1993

  26. Rötzschke, O., Falk, K., Wallny, H. J., Faath, S., and Rammensee, H.-G. Characterization of naturally occuring minor histocompatibility peptides including H-4 and H-Y. Science 249: 283–287, 1990

  27. Sanchez-Madrid, F., Krensky, A. M., Ware, C. F., Robbins, E., Strominger, J. L., Burakoff, S. J., and Springer, T. A. Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci USA 79: 7489–7493, 1982

  28. Scott, D., McLaren, A., Dyson, J., and Simpson, E. Variable spread of X inactivation affecting the expression of different epitopes of the Hya gene product in mouse B-cell clones. Immunogenetics 33: 54–61, 1991

  29. Silvers, W. K. and Yang, S. L. Male specific antigen: homology in mice and rats. Science 181: 570–572, 1973

  30. Simpson, E., Brunner, C., Hetherington, C., Chandler, P., Brenan, M., Dagg, M., and Bailey, D. W. H-Y antigen: no evidence for alleles in wild strains of mice. Immunogenetics 8: 213–219, 1979

  31. Taurog, J. D., Sandberg, G. P., and Mahowald, M. L. The cellular basis of adjuvant arthritis. I. Enhancement of cell-mediated passive transfer by concanavalin A and by immunosuppressive pre-treatment of the recipient. Cell Immunol 75: 271–282, 1983

  32. Taurog, J. D., Lowen, L., Forman, J., and Hammer, R. E. HLA-B27 in inbred and non-inbred transgenic mice. Cell surface expression and recognition as an alloantigen in the absence of human β2-microglobulin. J Immunol 141: 4020–4023, 1988

  33. Taurog, J. D., Hammer, R. E., Maika, S. D., Sams, K. L., El-Zaatari, F. A. K., Stimpson, S. A., and Schwab, J. H. HLA-B27 transgenic mice as potential models of human disease. In I. K. Egorov and C. S. David (eds.): Transgenic Mice and Mutants in MHC Research, pp. 268–275, Springer, Berlin Heidelberg New York, 1990

  34. Taurog, J. D., Maika, S. D., Simmons, W. A., Breban, M., and Hammer, R. E. Susceptability to inflammatory disease in HLA-B27 transgenic rat lines correlates with the level of B27 expression. J Immunol 150: 4168–4178, 1993

  35. Tiwari, J. L. and Terasaki, P. I. HLA and Disease Associations, Springer, New York Berlin Heidelberg, 1985

  36. Van Els, C.A., de Bueger, M. M., Kempenaar, J., Ponec, M., and Goulmy, E. Susceptability of human male keratinocytes to MHC-restricted H-Y-specific lysis. J Exp Med 170: 1469–1474, 1989

  37. Wachtel, S. S. H-Y Antigen and the Biology of Sex Determination, Grune and Stratton, New York, 1983

  38. White, R. A., Mason, D. W., Williams, A. F., Galfre, G., and Milstein, C. T-lymphocyte heterogeneity in the rat: separation of functional subpopulations using a monoclonal antibody. J Exp Med 148: 664–673, 1978

Download references

Author information

Additional information

Correspondence to: J. D. Taurog.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Simmons, W.A., Taurog, J.D., Hammer, R.E. et al. Sharing of an HLA-B27-restricted H-Y antigen between rat and mouse. Immunogenetics 38, 351–358 (1993).

Download citation


  • Transgenic Line
  • Peptide Antigen
  • Lymph Node Cell
  • Specific Lysis
  • Human Target